185 related articles for article (PubMed ID: 36152903)
21. O-GlcNAcylation and oxidation of proteins: is signalling in the cardiovascular system becoming sweeter?
Lima VV; Spitler K; Choi H; Webb RC; Tostes RC
Clin Sci (Lond); 2012 Oct; 123(8):473-86. PubMed ID: 22757958
[TBL] [Abstract][Full Text] [Related]
22. Acute Increases in Protein O-GlcNAcylation Dampen Epileptiform Activity in Hippocampus.
Stewart LT; Khan AU; Wang K; Pizarro D; Pati S; Buckingham SC; Olsen ML; Chatham JC; McMahon LL
J Neurosci; 2017 Aug; 37(34):8207-8215. PubMed ID: 28760863
[TBL] [Abstract][Full Text] [Related]
23. Identification of a diketopiperazine-based O-GlcNAc transferase inhibitor sensitizing hepatocellular carcinoma to CDK9 inhibition.
Shan X; Jiang R; Gou D; Xiang J; Zhou P; Xia J; Wang K; Huang A; Tang N; Huang L
FEBS J; 2023 Sep; 290(18):4543-4561. PubMed ID: 37247228
[TBL] [Abstract][Full Text] [Related]
24. Swim-exercised mice show a decreased level of protein O-GlcNAcylation and expression of O-GlcNAc transferase in heart.
Belke DD
J Appl Physiol (1985); 2011 Jul; 111(1):157-62. PubMed ID: 21493720
[TBL] [Abstract][Full Text] [Related]
25. Hexosamine biosynthetic pathway promotes the antiviral activity of SAMHD1 by enhancing O-GlcNAc transferase-mediated protein O-GlcNAcylation.
Hu J; Gao Q; Yang Y; Xia J; Zhang W; Chen Y; Zhou Z; Chang L; Hu Y; Zhou H; Liang L; Li X; Long Q; Wang K; Huang A; Tang N
Theranostics; 2021; 11(2):805-823. PubMed ID: 33391506
[No Abstract] [Full Text] [Related]
26. Changes in O-Linked N-Acetylglucosamine (O-GlcNAc) Homeostasis Activate the p53 Pathway in Ovarian Cancer Cells.
de Queiroz RM; Madan R; Chien J; Dias WB; Slawson C
J Biol Chem; 2016 Sep; 291(36):18897-914. PubMed ID: 27402830
[TBL] [Abstract][Full Text] [Related]
27. The essential role of O-GlcNAcylation in hepatic differentiation.
Robarts DR; Kotulkar M; Paine-Cabrera D; Venneman KK; Hanover JA; Zachara NE; Slawson C; Apte U
Hepatol Commun; 2023 Nov; 7(11):. PubMed ID: 37930118
[TBL] [Abstract][Full Text] [Related]
28. Exploring leukocyte O-GlcNAcylation as a novel diagnostic tool for the earlier detection of type 2 diabetes mellitus.
Springhorn C; Matsha TE; Erasmus RT; Essop MF
J Clin Endocrinol Metab; 2012 Dec; 97(12):4640-9. PubMed ID: 23066116
[TBL] [Abstract][Full Text] [Related]
29. O-GlcNAc transferase activates stem-like cell potential in hepatocarcinoma through O-GlcNAcylation of eukaryotic initiation factor 4E.
Cao B; Duan M; Xing Y; Liu C; Yang F; Li Y; Yang T; Wei Y; Gao Q; Jiang J
J Cell Mol Med; 2019 Apr; 23(4):2384-2398. PubMed ID: 30677218
[TBL] [Abstract][Full Text] [Related]
30. O-GlcNAcylation of SIX1 enhances its stability and promotes Hepatocellular Carcinoma Proliferation.
Chu Y; Jiang M; Wu N; Xu B; Li W; Liu H; Su S; Shi Y; Liu H; Gao X; Fu X; Chen D; Li X; Wang W; Liang J; Nie Y; Fan D
Theranostics; 2020; 10(21):9830-9842. PubMed ID: 32863962
[TBL] [Abstract][Full Text] [Related]
31. Essential role of O-GlcNAcylation in stabilization of oncogenic factors.
Makwana V; Ryan P; Patel B; Dukie SA; Rudrawar S
Biochim Biophys Acta Gen Subj; 2019 Aug; 1863(8):1302-1317. PubMed ID: 31034911
[TBL] [Abstract][Full Text] [Related]
32. The positive feedback between ACSL4 expression and O-GlcNAcylation contributes to the growth and survival of hepatocellular carcinoma.
Wang J; Wang Z; Yuan J; Wang J; Shen X
Aging (Albany NY); 2020 May; 12(9):7786-7800. PubMed ID: 32357142
[TBL] [Abstract][Full Text] [Related]
33. Modification of p27 with O-linked N-acetylglucosamine regulates cell proliferation in hepatocellular carcinoma.
Qiu H; Liu F; Tao T; Zhang D; Liu X; Zhu G; Xu Z; Ni R; Shen A
Mol Carcinog; 2017 Jan; 56(1):258-271. PubMed ID: 27175940
[TBL] [Abstract][Full Text] [Related]
34. Intracellular protein O-GlcNAc modification integrates nutrient status with transcriptional and metabolic regulation.
Nagel AK; Ball LE
Adv Cancer Res; 2015; 126():137-66. PubMed ID: 25727147
[TBL] [Abstract][Full Text] [Related]
35. Protein O-GlcNAcylation: a new signaling paradigm for the cardiovascular system.
Laczy B; Hill BG; Wang K; Paterson AJ; White CR; Xing D; Chen YF; Darley-Usmar V; Oparil S; Chatham JC
Am J Physiol Heart Circ Physiol; 2009 Jan; 296(1):H13-28. PubMed ID: 19028792
[TBL] [Abstract][Full Text] [Related]
36. Aberrant O-GlcNAc-modified proteins expressed in primary colorectal cancer.
Phueaouan T; Chaiyawat P; Netsirisawan P; Chokchaichamnankit D; Punyarit P; Srisomsap C; Svasti J; Champattanachai V
Oncol Rep; 2013 Dec; 30(6):2929-36. PubMed ID: 24126823
[TBL] [Abstract][Full Text] [Related]
37. O-GlcNAc modification affects the ATM-mediated DNA damage response.
Miura Y; Sakurai Y; Endo T
Biochim Biophys Acta; 2012 Oct; 1820(10):1678-85. PubMed ID: 22759405
[TBL] [Abstract][Full Text] [Related]
38. Posttranslational, reversible O-glycosylation is stimulated by high glucose and mediates plasminogen activator inhibitor-1 gene expression and Sp1 transcriptional activity in glomerular mesangial cells.
Goldberg HJ; Whiteside CI; Hart GW; Fantus IG
Endocrinology; 2006 Jan; 147(1):222-31. PubMed ID: 16365142
[TBL] [Abstract][Full Text] [Related]
39. Developmental regulation of protein O-GlcNAcylation, O-GlcNAc transferase, and O-GlcNAcase in mammalian brain.
Liu Y; Li X; Yu Y; Shi J; Liang Z; Run X; Li Y; Dai CL; Grundke-Iqbal I; Iqbal K; Liu F; Gong CX
PLoS One; 2012; 7(8):e43724. PubMed ID: 22928023
[TBL] [Abstract][Full Text] [Related]
40. O-GlcNAcylation and neurodegeneration.
Wani WY; Chatham JC; Darley-Usmar V; McMahon LL; Zhang J
Brain Res Bull; 2017 Jul; 133():80-87. PubMed ID: 27497832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
